This page is obsolete: please read the new version.

Analysis of myocardial [13N]ammonia PET studies

Background

First-pass myocardial extraction of [13N]ammonia ([13N]NH3) is very high, close to one, when perfusion is normal or lower than normal, and even for flow values up to 5 ml/(min*100 g) over 90% (Schelbert et al., 1981). Following the initial extraction across the capillary membranes and via passive diffusion as [13N]NH3 or via active transport as ammonium ion, [13N]NH4+, into the muscle cells, [13N]ammonia is either incorporated into the amino acid pool as [13N]glutamine or it diffuses back into the blood. The myocardial metabolic retention is an adenosine triphosphate -dependent process, whichmay become a rate-limiting step in uptake at high perfusion levels. Thus uptake and retention can both be altered by changes in the metabolic state of the myocardium (Schelbert et al., 1981; Machac et al., 2006).

Analysis methods used in literature

The calculation models should include corrections for the partial volume effect and spillover from the left cavity onto the ventricular myocardium. Methods may also account for the dependency of myocardial extraction on blood flow.

Arterial blood input

Arterial blood curve is the input to the calculation models, and the LV TAC from PET image can directly represent that in case of adult humans and modern PET scanners (Weinberg et al., 1988). Using left atrial input function instead of left ventricular input function may provide better compartment model fits and higher flowvalues because of lower spillover from myocardium (Hove et al., 2004).

Metabolites of [13N]ammonia in blood

Over 90% of the blood radioactivity within the first two minutes is present as [13N]ammonia, but at 3-5 min the recirculating 13N carrying metabolites, mainly glutamine and urea, represent about half of the blood radioactivity (Rosenspire et al., 1990; Müller et al., 1994). Yet, the effect of metabolites in blood on myocardial blood flowmeasurements is relatively small, especially to the compartment model parameter representing blood flow, and correction for metabolic contamination may not be necessary (Hutchins et al., 1990; Muzik et al., 1993), and is generally not applied if only the first 2 minutes are used in the model fit. The total scan length can be shortened to reduce the effect of blood metabolites (DeGrado et al., 1996).

Arterial blood data can be corrected for the metabolites by measuring individually the fractions of parent [13N]ammonia from blood samples during the study (Müller et al., 1994). The average fraction curves published by Rosenspire et al., (1990) or Müller et al. (1994) have been commonly used to make an approximate metabolite correction (Choi et al., 1999).

Fraction of parent ammonia
Figure 1. Symbols represent the measured averaged (n=11) fractions of parent tracer in blood as published by Müller et al. (1994). Lines represent "Hill-type" function fits to the data.

Compartment models

A two-tissue compartment model (Hutchins et al., 1990; Muzik et al., 1993; Sawada et al., 1995) has been widely used to estimate myocardial blood flow with [ 13N]ammonia. The first tissue compartment represents interstitial and intracellular [13N]ammonia, and the second tissue compartment represents the intracellular metabolic products of [13N]ammonia. Intracellular metabolism is assumed to be irreversible process during the PET scan (k4=0). Four model parameters are fitted, K1, k2, k3, and tissue blood volume. A generalized linear least squares (GLLS) method has also been proposed to generate parametric blood flow (K1) images, accounting for bidirectional spillover effects, but not for partial volume effect (Chen et al., 1998).

Partial volume and spill-over effects were incorporated in the two-tissue compartment model through the parameter for tissue blood volume, assuming a geometrical model (Hutchins et al., 1990; 1992; Nitzsche et al., 1996); this may be considered appropriate when myocardial ROIs are placed so that they contain only myocardial tissue and blood pool (DeGrado et al., 2000; Choi et al., 1999). Alternatively, these effects can be corrected based on measured myocardium wall thickness and scanner resolution (Krivokapich et al., 1989). Spillover effects could also be corrected with the help of factor analysis (Wu et al., 1995).

Parameters k3 and k2 can be constrained based on K1, so that only two parameters are fitted (K1and tissue blood volume). In this case fit time is usually reduced to 2 minutes after injection (Krivokapich et al., 1989; Nitzsche et al., 1996; Choi et al., 1999). Smaller number of fitted parameters leads to lower SD of flowestimates, and shorter scan period minimizes subject motion artifacts, at the cost of introducing additional assumptions. A modification of these assumptions was suggested by Hickey et al. (2005) to achieve higher perfusion estimates, closer to estimates from [15O]H2O PET.

One-tissue compartment model (k3=0) was already suggested by Hutchins et al. (1990), but DeGrado et al. (1996) shortened the fit time from 10 to 4 minutes; during that time the metabolically trapped tracer was not kinetically distinguished. This method minimizes the effects of radioactive metabolites in the blood (DeGrado et al., 1996). For septum, two-tissue compartment model was shown to be superior to one-tissue compartment model, even with short fit time and when RV spillover was taken into account (Hove et al., 2003).

Graphical analysis (Patlak plot)

Choi et al. (1993) suggested using graphical analysis for irreversible tracers ("Patlak plot") to estimate the blood flow using the PET data from 70 to 120 s after injection. To produce parametric flow images with acceptable noise level the intercepts of the plots had to be constrained to physiological range (Choi et al., 1993). The slope of the plot would have to be corrected to reach an estimate of blood flow (Choi et al., 1993), which in practice may be impossible (Chen et al. 1998). The result is strongly dependent on the fit time (Mullani, 1993). Usage of other (fast) methods for analysis of [ 13N]ammonia data are recommended.

Retention model

Bellina et al. (1990) suggested a method based on calculation of retention index (tissue activity divided by integral of input curve). Retention is simple to calculate, but retention factor (not extraction factor, which is always close to one) is severely decreased with increasing flow and impacted by changes in metabolic state of the myocardium than the blood flow estimate from compartment model.

Simulations

Glatting and Reske (1999) have studies using simulations the effect of including the correction for physical decay into the model equations. They found no effect in the mean quantitative values. Chen et al. (1998) used simulations to validate a GLLS method for generation of parametric flow images. Golish et al. (2001) simulated data to validate a nonlinear method for producing parametric images.

Suggested analysis method

Our current suggestion is to apply two-tissue compartment model (K1, k2, k3) with geometrical model correction for spillover and partial volume effects. This method is implemented in CarimasTurku.

To calculate quantitative perfusion values, a nonlinear extraction correction is needed. Parameters for the correction functions may need to be determined for each institute, unless the study protocols are similar. To start with, CarimasTurku implements the extraction correction function from (Yoshida et al., 1996).

With suggested model, the influence of blood metabolite correction is negligible on the blood flow estimates (Muzik et al., 1993). If metabolite correction is required, then we suggest that it is based on average fraction curves measured in rest, adenosine, or adenosine-plus-exercise studies (Müller et al., 1994) and fitted with Hill-type function (Fig. 1). Currently, CarimasTurku does not contain option for metabolite correction.



References

Bellina CR, Parodi O, Camici P, Salvadori PA, Taddei L, Fusani L, Guzzardi R, Klassen GA, L'Abbate A, Donato L. Simultaneous in vitro and in vivo validation of nitrogen-13-ammonia for the assessment of regional myocardial blood flow. J Nucl Med. 1990; 31: 1335-1343.

Chen K, Lawson M, Reiman E, Cooper A, Feng D, Huang S-C, Bandy D, Ho D, Yun L, Palant A. Generalized linear least squares method for fast generation of myocardial blood flow parametric images with N-13 ammonia PET. IEEE Trans Med Imaging 1998; 17(2): 236-234.

Choi Y, Huang S-C, Hawkins RA, Kuhle WG, Dahlbom M, Hoh CK, Czernin J, Phelps ME, Schelbert HR. J Nucl Med. 1993; 34(3): 488-497.

Choi Y, Huang S-C, Hawkins RA, Kim JY, Kim B-T, Hoh CK, Chen K, Phelps ME, Schelbert HR. Quantification of myocardial blood flow using 13N-ammonia and PET: comparison of tracer models. J Nucl Med. 1999; 40: 1045-1055.

DeGrado TR, Bergmann SR, Ng CK, Raffel DM. Tracer kinetic modeling in nuclear cardiology. J Nucl Cardiol. 2000; 7: 686-700.

DeGrado TR, Hanson MW, Turkington TG, Delong DM, Brezinski DA, Vallée J-P, Hedlund LW, Zhang J, Cobb F, Sullivan MJ, Coleman RE. Estimation of myocardial blood flow for longitudinal studies with 13N-labeled ammonia and positron emission tomography. J Nucl Cardiol. 1996; 3: 494-507.

de Jong HWAM, Lubberink M. Issues in quantification of cardiac PET studies. Eur J Nucl Med Mol Imaging 2007; 34: 316-319.

Glatting G, Reske SN. Treatment of radioactive decay in pharmacokinetic modeling: influence on parameter estimation in cardiac 13N-PET. Med Phys. 1999; 26(4): 616-621.

Golish SR, Hove JD, Schelbert HR, Gambhir SS. A fast nonlinear method for parametric imaging of myocardial perfusion by dynamic 13N-ammonia PET. J Nucl Med. 2001; 42: 924-931.

Hickey KT, Sciacca RR, Chou RL, Rodriguez O, Bokhari S, Bergmann SR. An improved model for the measurement of myocardial perfusion in human beings using N-13 ammonia. J Nucl Cardiol. 2005; 12(3):311-317.

Hove JD, Gambhir SS, Kofoed KF, Freiberg J, Kelbæk H. Quantitation of the regional blood flow in the interventricular septum using positron emission tomography and nitrogen-13 ammonia. Eur J Nucl Med 2003; 30: 109-116.

Hove JD, Iida H, Kofoed KF, Freiberg J, Holm S, Kelbæk H. Left atrial versus left ventricular input function for quantification of the myocardial blood flow with nitrogen-13 ammonia and positron emission tomography. Eur J Nucl Med. 2004; 31: 71-76.

Hutchins GD, Caraher JM, Raylman RR. A region of interest strategy for minimizing resolution distortions in quantitative myocardial PET studies. J Nucl Med. 1992; 33: 1243-1250.

Hutchins GD, Schwaiger M, Rosenspire KC, Krivokapich J, Schelbert H, Kuhl DE. Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol. 1990; 15(5): 1032-1042.

Khorsand A, Graf S, Pirich C, Muzik O, Kletter K, Dudczak R, Maurer G, Sochor H, Schuster E, Porenta G. Assessment of myocardial perfusion by dynamic N-13 ammonia PET imaging: comparison of 2 tracer kinetic models. J Nucl Cardiol. 2005; 12: 410-417.

Krivokapich J, Smith GT, Huang S-C, Hoffman EJ, Ratib O, Phelps ME, Schelbert HR. 13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Circulation 1989; 80: 1328-1337.

Machac J, Bacharach SL, Bateman TM, Bax JJ, Beanlands R, Bengel F, Bergmann SR, Brunken RC, Case J, Delbeke D, DiCarli MF, Garcia EV, Goldstein RA, Gropler RJ, Travin M, Patterson R, Schelbert HR. Positron emission tomography myocardial perfusion and glucose metabolism imaging. J Nucl Cardiol. 2006; 13: e121-e151.

Mullani NA. Is the Patlak graphical analysis method applicable to measurement of myocardial blood flow with nitrogen-13-ammonia? J Nucl Med. 1993; 34(10): 1831-1832.

Muzik O, Beanlands RSB, Hutchins GD, Mangner TJ, Nguyen N, Schwaiger M. Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET. J Nucl Med. 1993; 34: 83-91.

Müller P, Czernin J, Choi Y, Aguilar F, Nitzsche EU, Buxton DB, Sun K, Phelps ME, Huang S-C, Schelbert HR. Effect of exercise supplementation during adenosine infusion on hyperemic blood flow and flow reserve. Am Heart J. 1994; 128(1): 52-60.

Nitzsche EU, Choi Y, Czernin J, Hoh CK, Huang S-C, Schelbert HR. Noninvasive quantification of myocardial blood flow in humans. A direct comparison of the [13N]ammonia and the [15O]water techniques. Circulation 1996; 93: 2000-2006.

Rosenspire KC, Schwaiger M, Mangner TJ, Hutchins GD, Sutorik A, Kuhl DE. Metabolic fate of [13N]ammonia in human and canine blood. J Nucl Med. 1990; 31: 163-167.

Sawada S, Muzik O, Beanlands RSB, Wolfe E, Hutchins GD, Schwaiger M. Interobserver and interstudy variability of myocardial blood flow and flow-reserve measurements with nitrogen 13 ammonia-labeled positron emission tomography. J Nucl Cardiol. 1995; 2: 413-422.

Schelbert HR, Phelps ME, Huang S-C, MacDonald NS, Hansen H, Selin C, Kuhl DE. Circulation 1981; 63(6): 1259-1272.

Weinberg IN, Huang SC, Hoffman EJ, Araujo L, Nienaber C, Grover-McKay M, Dahlbom M, Schelbert H. Validation of PET-acquired input functions for cardiac studies. J Nucl Med. 1988; 29: 241-247.

Wu H-M, Hoh CK, Buxton DB, Kuhle WG, Schelbert HR, Choi Y, Hawkins RA, Phelps ME, Huang S-C. Quantification of myocardial blood flow using dynamic nitrogen-13-ammonia PET studies and factor analysis of dynamic structures. J Nucl Med. 1995; 36: 2087-2093.

Yoshida K, Mullani N, Gould KL. Coronary flow and flow reserve by PET simplified for clinical applications using rubidium-82 or nitrogen-13-ammonia. J Nucl Med. 1996; 37: 1701-1712.



Valid XHTML 1.0 Strict Valid CSS!